Diversified Healthcare Trust (NASDAQ:DHC) Stock Rating Upgraded by Royal Bank Of Canada

Diversified Healthcare Trust (NASDAQ:DHC) was upgraded by analysts at Royal Bank Of Canada from an “underperform” rating to a “sector perform” rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm presently has a $5.00 target price on the real estate investment trust’s stock, up from their prior target price of $3.00. Royal Bank Of Canada’s price objective would indicate a potential upside of 7.99% from the company’s current price.

A number of other research firms also recently commented on DHC. B. Riley lifted their price target on Diversified Healthcare Trust from $4.50 to $5.50 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Diversified Healthcare Trust in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.25.

Diversified Healthcare Trust Stock Down 2.9%

Shares of NASDAQ:DHC opened at $4.63 on Thursday. The firm has a market cap of $1.12 billion, a PE ratio of -3.89 and a beta of 2.61. The company has a fifty day simple moving average of $4.34 and a 200 day simple moving average of $3.72. The company has a current ratio of 6.35, a quick ratio of 6.35 and a debt-to-equity ratio of 1.42. Diversified Healthcare Trust has a 12-month low of $2.00 and a 12-month high of $4.99.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings data on Monday, June 2nd. The real estate investment trust reported $0.01 EPS for the quarter. The firm had revenue of $370.78 million for the quarter. Diversified Healthcare Trust had a negative net margin of 18.83% and a negative return on equity of 14.69%.

Institutional Trading of Diversified Healthcare Trust

Several hedge funds have recently made changes to their positions in the stock. Creative Planning boosted its position in Diversified Healthcare Trust by 753.7% during the 3rd quarter. Creative Planning now owns 239,558 shares of the real estate investment trust’s stock valued at $1,056,000 after purchasing an additional 211,498 shares during the period. Brooklyn Investment Group increased its position in Diversified Healthcare Trust by 21.1% in the third quarter. Brooklyn Investment Group now owns 22,153 shares of the real estate investment trust’s stock worth $98,000 after buying an additional 3,865 shares during the period. Brigade Capital Management LP lifted its stake in Diversified Healthcare Trust by 47.9% in the third quarter. Brigade Capital Management LP now owns 1,600,000 shares of the real estate investment trust’s stock valued at $7,056,000 after buying an additional 518,357 shares during the last quarter. Caption Management LLC boosted its holdings in shares of Diversified Healthcare Trust by 17.0% during the third quarter. Caption Management LLC now owns 46,781 shares of the real estate investment trust’s stock valued at $206,000 after acquiring an additional 6,781 shares during the period. Finally, Quinn Opportunity Partners LLC boosted its holdings in shares of Diversified Healthcare Trust by 9.8% during the third quarter. Quinn Opportunity Partners LLC now owns 449,660 shares of the real estate investment trust’s stock valued at $1,983,000 after acquiring an additional 40,000 shares during the period. Institutional investors own 75.98% of the company’s stock.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.